Latest news

Posts about investor

World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge

Dr. Paul Opgenorth

eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing

Chris Marlett, MDB Capital

Slack Capital interview: Chris Marlett, Chairman of the Board

Slack Capital interview: Damien Perriman, CCO

Michael Heltzen & Erum Azeez Khan

eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on Grow Everything podcast

Tyler Korman

Slack Capital interview: Tyler Korman, VP of Research

Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update

Slack Capital: EXOZ investment report and CEO interview

eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today

eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST